Cenegermin-Bkbj

OXERVATE

Recombinant Human Nerve Growth Factor

NADAC/unit N/A

No Shortage Tier 1: 2.7% PA Req: 16.4%

OXERVATE ® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.

Covered Lives

Explore in the Ecosystem

rxsaver.aiCompare prices for Cenegermin-Bkbj drfinder.aiFind doctors who prescribe Cenegermin-Bkbj rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Cenegermin-Bkbj

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.